Schwab International Core Equity Fund (SICNX) is a Foreign Large Blend fund with $887.86 Million in assets. The fund allocates 19.21% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Novo Nordisk A/S at 2.42% of total assets. This is followed by ASML Holding NV (2.16%) and Novartis AG (2.28%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Novo Nordisk A/S | 2.42% | - | - |
| ASML Holding NV | 2.16% | - | - |
| Novartis AG | 2.28% | - | - |
| Shell PLC | 1.86% | - | - |
| SAP SE | 2.31% | - | - |
| Sumitomo Mitsui Financial Group Inc | 1.82% | - | - |
| Deutsche Telekom AG | 2.03% | - | - |
| State Street Institutional US Government Money Market Fund | 1.58% | - | - |
| GSK PLC | 1.39% | - | - |
| Imperial Brands PLC | 1.36% | - | - |
| Sony Group Corp | 2.39% | - | - |
| Roche Holding AG | 1.97% | - | - |
| ABB Ltd | 1.64% | - | - |
| Allianz SE | 1.76% | - | - |
| HSBC Holdings PLC | 2.13% | - | - |
| Rolls-Royce Holdings PLC | 1.84% | - | - |
| AstraZeneca PLC | 1.72% | - | - |
| BNP Paribas SA | 1.58% | - | - |